ARTICLE | Company News
CollaGenex, QuatRx deal
May 21, 2007 7:00 AM UTC
QuatRx granted CGPI exclusive, worldwide rights, excluding Japan, to develop and commercialize becocalcidiol to treat psoriasis and other skin diseases. The vitamin D analog ointment met the primary e...